Holen Sie sich die Stockscreener-App
18.73
1.30%
0.24
Handel nachbörslich:
18.73
Schlusskurs vom Vortag:
$18.49
Offen:
$18.62
24-Stunden-Volumen:
2.60M
Relative Volume:
1.08
Marktkapitalisierung:
$4.72B
Einnahmen:
$810.81M
Nettoeinkommen (Verlust:
$156.02M
KGV:
29.64
EPS:
0.6319
Netto-Cashflow:
$373.47M
1W Leistung:
+1.46%
1M Leistung:
-10.68%
6M Leistung:
-2.35%
1J Leistung:
+2.13%
1-Tages-Spanne:
$18.57
$18.84
1-Wochen-Bereich:
$17.80
$19.21
52-Wochen-Spanne:
$17.16
$21.28
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBRA
Sabra Healthcare Reit Inc
|
18.73 | 4.72B | 810.81M | 156.02M | 373.47M | 0.6319 |
WELL
Welltower Inc
|
214.23 | 151.23B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
84.60 | 41.13B | 6.13B | 272.21M | 1.38B | 0.5521 |
DOC
Healthpeak Properties Inc
|
20.69 | 14.26B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
45.77 | 13.63B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
46.81 | 9.68B | 2.37B | 101.67M | 169.19M | 0.5775 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
GSI Capital Advisors LLC Purchases New Shares in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
2,654,480 Shares in Sabra Healthcare REIT, Inc. $SBRA Acquired by Centersquare Investment Management LLC - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Bank of New York Mellon Corp - MarketBeat
Stocks Bearish Tomorrow - Intellectia AI
Sabra Health Care REIT Stock Slides -15% With A 7-Day Losing Spree - Trefis
How The Sabra Health Care REIT (SBRA) Investment Story Is Evolving With Recent Updates - Yahoo Finance
Sabra Health Care REIT (SBRA) director granted 817 dividend-equivalent stock units - Stock Titan
Sabra Health Care REIT (SBRA) director receives 817 stock units grant - Stock Titan
Sabra Health Care (SBRA) director receives 817 stock units - Stock Titan
Sabra Health Care (SBRA) director gifts shares and receives stock units - Stock Titan
Sabra Health Care REIT (SBRA) director receives 817 stock units via dividend equivalents - Stock Titan
Sabra Health Care REIT (SBRA) director granted 817 stock units as dividend equivalents - Stock Titan
Sabra Health Care REIT (SBRA) EVP granted 385 dividend-equivalent stock units - Stock Titan
Sabra (NASDAQ: SBRA) EVP Darrin Smith awarded 501 dividend-equivalent shares - Stock Titan
Sabra Health Care REIT (SBRA) CFO receives 4,200 dividend-based stock units - Stock Titan
Sabra Health Care REIT (SBRA) CEO receives 14,003 stock units award - Stock Titan
Sabra Healthcare REIT Is Maintained at Overweight by Wells Fargo - Moomoo
Lasalle Investment Management Securities LLC Purchases New Shares in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Legal & General Group Plc Has $27.03 Million Stake in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
SBRA Stock Price, Quote & Chart | SABRA HEALTH CARE REIT INC (NASDAQ:SBRA) - ChartMill
Sabra Health Care REIT to Present at Nareit’s REITweek 2026 Investor Conference - geneonline.com
Sabra (NASDAQ: SBRA) director reports 490-share gift and updates stock holdings - Stock Titan
Sabra Healthcare REIT Highlights Strategic Senior Housing Expansion - TipRanks
Sabra Health Care REIT : Investor Presentation - marketscreener.com
Top Sabra Health Care REIT executives head to New York investor summit - Stock Titan
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit’s REITweek 2026 Investor Conference - marketscreener.com
Sabra Health Care REIT (NASDAQ: SBRA) outlines $277M deals and $7.8B value - Stock Titan
Sabra (NASDAQ: SBRA) director makes 813-share stock gift, holds 73k - Stock Titan
Analysts Offer Insights on Real Estate Companies: American Healthcare REIT, Inc. (AHR) and Federal Realty (FRT) - The Globe and Mail
Systematic Financial Management LP Has $41.91 Million Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
FVR vs. SBRA: Which Stock Is the Better Value Option? - qz.com
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA) - Seeking Alpha
Sabra Health Care REIT stock (US78396U1051): dividend-focused healthcare landlord after latest earni - AD HOC NEWS
Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance - Quantisnow
Sabra Healthcare REIT, Inc. $SBRA Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Sabra Healthcare REIT stock hits 52-week high at 21.07 USD - Investing.com Canada
Sabra Healthcare REIT Is Maintained at Neutral by Cantor Fitzgerald - Moomoo
Cantor Fitzgerald raises Sabra Healthcare REIT price target to $22 By Investing.com - Investing.com South Africa
Cantor Fitzgerald raises Sabra Healthcare REIT price target to $22 - Investing.com UK
Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Is Higher Q1 Revenue And An Affirmed Dividend Altering The Investment Case For Sabra (SBRA)? - simplywall.st
UBS Group AG Raises Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT (NASDAQ:SBRA) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Sabra Health Care REIT: A 6% Yield Backed By Powerful Demographic Tailwinds (SBRA) - Seeking Alpha
The reasons Sabra (SBRA) could be underpriced (+0.39%) 2026-05-07Wyckoff Accumulation - thelegaladvocate.com
Mitsubishi UFJ Trust & Banking Corp Sells 111,862 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Principal Financial Group Inc. Acquires 4,431,897 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):